This is what I’m expecting in terms of news and timelines:1....

This is what I’m expecting in terms of news and timelines:

1. More data from the SAS program, as noted in the AGM, this is imminent. I would be interested if there was any further Biomarker results, as this is as Paul stated is more of an objective measure, and one that is seen as breakthrough in the OA space, one to watch.
2. TGA meeting results - PAR may release something on the progress eg meeting went well etc, they now know what is required to progress to TGA approval, may update on timeline of expected conclusion. Next few weeks I gather.
3. US ex NFL player dosages - 1st one in Dec2019, complete by Jan2020. First results will be late Feb2020.
4. US FDA meeting of phase 3 OA design - 1st qtr 2020.
5. US/Europe regulatory meetings of MPS Phase2/3 design - Jan/Feb2020.
6. Ongoing results of Aus SAS program - Feb2020
7. Research publication of MPS/OA? Wasn’t sure but this was mentioned in the AGM (Mozzarc and others any ideas on this?)
8. Ongoing discussion with Partners, it was alluded to at the AGM, the board will have a discussion on what sort of partners they are looking for, could have some news here - Jan/Feb2020.
9. Alpha virus news with US Defense - I’m assuming there be news of further collaboration.

Not sure if I’ve missed anything of upcoming news, pls feel free to fill in the gaps. As you can see there’s plenty of news coming.